Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Andrei Iagaru
With
General Electric
Primary Objective: To determine feasibility of 68Ga-PSMA-11 PET/MRI and 68Ga-RM2 PET/MRI for evaluation of HIFU or HDR local therapy in patients with known prostate cancer.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Known prostate cancer
Planned HIFU or HDR local therapy
Able to provide written consent
Karnofsky performance status of 50 (or Eastern Cooperative Oncology Group (ECOG) /World Health Organization (WHO) equivalent)
You may not be if
Patients not capable of getting PET study due to weight, claustrophobia, or inability to lay still for the duration of the exam
Metallic implants (contraindicated for MRI)
Clareo Health | 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy
